A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice?
ABSTRACT Purpose: To evaluate the trend of use of Prostate Specific Antigen (PSA) for screening of prostate cancer (PC) among Brazilian doctors, from the beginning of its regular availability in clinical laboratories. Material and Methods: A serial cross-sectional study was performed using data ob...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sociedade Brasileira de Urologia
|
| Series: | International Brazilian Journal of Urology |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000300478&lng=en&tlng=en |
| _version_ | 1818696322943811584 |
|---|---|
| author | Fernando Antônio Glasner da Rocha Araújo Nairo Massakazu Sumita Ubirajara de Oliveira Barroso Jr. |
| author_facet | Fernando Antônio Glasner da Rocha Araújo Nairo Massakazu Sumita Ubirajara de Oliveira Barroso Jr. |
| author_sort | Fernando Antônio Glasner da Rocha Araújo |
| collection | DOAJ |
| description | ABSTRACT Purpose: To evaluate the trend of use of Prostate Specific Antigen (PSA) for screening of prostate cancer (PC) among Brazilian doctors, from the beginning of its regular availability in clinical laboratories. Material and Methods: A serial cross-sectional study was performed using data obtained from a large database between 1997 and 2016. The general PSA screening trend during this period, adjusted for the total number of exams performed in men, was analyzed. Time-series analysis was performed through observation of the general regression curve using the generalized least squares method, and the impact of the recommendations was assessed with autoregressive integrated moving average (ARIMA) models. Results: During the period studied 2,521,383 PSA determinations were done. The age of the participants ranged from 21 to 111 years, with an average of 56.7 ± 22.7 years. The relative number of PSA tests/100.000 exams in males showed a constant reduction since 2001, and this trend was more evident in the group aged 55-69 years. Although statistically significant, the impact of reduced PSA screening after the 2012 USPSTF publication was clinically irrelevant. Conclusions: Our results indicated a continuous reduction in the use of PSA screening over time, regardless of the publication of recommendations or clinical guidelines. The fact that this trend was more pronounced among those with a greater benefit potential (55-69 years), relative to groups with a greater damage potential due to overdiagnosis and overtreatment (aged >74 years and <40 years), is a matter of concern. Follow-up studies of these trends are advisable. |
| first_indexed | 2024-12-17T13:59:32Z |
| format | Article |
| id | doaj.art-faab003fa67b40fb94e3f7d2c33b1415 |
| institution | Directory Open Access Journal |
| issn | 1677-6119 |
| language | English |
| last_indexed | 2024-12-17T13:59:32Z |
| publisher | Sociedade Brasileira de Urologia |
| record_format | Article |
| series | International Brazilian Journal of Urology |
| spelling | doaj.art-faab003fa67b40fb94e3f7d2c33b14152022-12-21T21:45:51ZengSociedade Brasileira de UrologiaInternational Brazilian Journal of Urology1677-611945347848510.1590/s1677-5538.ibju.2018.0179S1677-55382019000300478A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice?Fernando Antônio Glasner da Rocha AraújoNairo Massakazu SumitaUbirajara de Oliveira Barroso Jr.ABSTRACT Purpose: To evaluate the trend of use of Prostate Specific Antigen (PSA) for screening of prostate cancer (PC) among Brazilian doctors, from the beginning of its regular availability in clinical laboratories. Material and Methods: A serial cross-sectional study was performed using data obtained from a large database between 1997 and 2016. The general PSA screening trend during this period, adjusted for the total number of exams performed in men, was analyzed. Time-series analysis was performed through observation of the general regression curve using the generalized least squares method, and the impact of the recommendations was assessed with autoregressive integrated moving average (ARIMA) models. Results: During the period studied 2,521,383 PSA determinations were done. The age of the participants ranged from 21 to 111 years, with an average of 56.7 ± 22.7 years. The relative number of PSA tests/100.000 exams in males showed a constant reduction since 2001, and this trend was more evident in the group aged 55-69 years. Although statistically significant, the impact of reduced PSA screening after the 2012 USPSTF publication was clinically irrelevant. Conclusions: Our results indicated a continuous reduction in the use of PSA screening over time, regardless of the publication of recommendations or clinical guidelines. The fact that this trend was more pronounced among those with a greater benefit potential (55-69 years), relative to groups with a greater damage potential due to overdiagnosis and overtreatment (aged >74 years and <40 years), is a matter of concern. Follow-up studies of these trends are advisable.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000300478&lng=en&tlng=enProstatic NeoplasmsProstate-Specific AntigenMass Screening |
| spellingShingle | Fernando Antônio Glasner da Rocha Araújo Nairo Massakazu Sumita Ubirajara de Oliveira Barroso Jr. A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice? International Brazilian Journal of Urology Prostatic Neoplasms Prostate-Specific Antigen Mass Screening |
| title | A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice? |
| title_full | A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice? |
| title_fullStr | A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice? |
| title_full_unstemmed | A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice? |
| title_short | A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice? |
| title_sort | continuous fall of psa use for prostate cancer screening among brazilian doctors since 2001 good or bad notice |
| topic | Prostatic Neoplasms Prostate-Specific Antigen Mass Screening |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000300478&lng=en&tlng=en |
| work_keys_str_mv | AT fernandoantonioglasnerdarochaaraujo acontinuousfallofpsauseforprostatecancerscreeningamongbraziliandoctorssince2001goodorbadnotice AT nairomassakazusumita acontinuousfallofpsauseforprostatecancerscreeningamongbraziliandoctorssince2001goodorbadnotice AT ubirajaradeoliveirabarrosojr acontinuousfallofpsauseforprostatecancerscreeningamongbraziliandoctorssince2001goodorbadnotice AT fernandoantonioglasnerdarochaaraujo continuousfallofpsauseforprostatecancerscreeningamongbraziliandoctorssince2001goodorbadnotice AT nairomassakazusumita continuousfallofpsauseforprostatecancerscreeningamongbraziliandoctorssince2001goodorbadnotice AT ubirajaradeoliveirabarrosojr continuousfallofpsauseforprostatecancerscreeningamongbraziliandoctorssince2001goodorbadnotice |